Rapid Whole Genome Sequencing in Critically Ill Neonates Enables Precision Medicine Pipeline

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Rapid genome sequencing in critically ill infants is increasingly identified as a crucial test for providing targeted and informed patient care. We report the outcomes of a pilot study wherein eight critically ill neonates received rapid whole genome sequencing with parental samples in an effort to establish a prompt diagnosis. Our pilot study resulted in a 37.5% diagnostic rate by whole genome sequencing alone and an overall 50% diagnostic rate for the cohort. We describe how the diagnoses led to identification of additional affected relatives and a change in management, the limitations of rapid genome sequencing, and some of the challenges with sample collection. Alongside this pilot study, our site simultaneously established a research protocol pipeline that will allow us to conduct research-based genomic testing in the cases for which a diagnosis was not reached by rapid genome sequencing or other available clinical testing. Here we describe the benefits, limitations, challenges, and potential for rapid whole genome sequencing to be incorporated into routine clinical evaluation in the neonatal period.
Funding Information
  • Rady Children’s Institute for Genomic Medicine
  • Neonatal Perinatal Research Unit at Duke University
  • Y.T. and Alice Chen Pediatric Genetics and Genomics Research Center

This publication has 10 references indexed in Scilit: